Israel Biotech Fund is a Rehovot-based venture capital firm investing exclusively in Israeli and Israeli-related biotechnology and pharmaceutical companies developing drug therapeutics. The firm targets therapeutic assets with strong scientific rationale and commercial potential, including oncology and broader life sciences opportunities, and supports portfolio companies with venture advisors and strategic, operational and business development resources. It is most relevant for founders building biotech or pharmaceutical drug-development companies connected to Israel.